Chagas disease is a chronic parasitological disease, which could cause cardiac manifestations in approximately one-third of affected individuals. Benznidazole and nifurtimox are used to treat this parasitological infection caused by Trypanosoma cruzi. Conventionally, the criterion for cure is consistently negative serological tests after treatment. We report a case of a patient who was treated when she was 13 years old and achieved T. cruzi negative seroconversion but developed Chagas disease cardiomyopathy as an adult.
CITATION STYLE
Fernández, M. L., Hernández, Y., Scollo, K., Esteva, M. I., Riarte, A. R., & Prado, N. G. (2018). Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhood. Revista Da Sociedade Brasileira de Medicina Tropical, 51(4), 557–559. https://doi.org/10.1590/0037-8682-0364-2017
Mendeley helps you to discover research relevant for your work.